|
|
Volumn 1, Issue 3, 2001, Pages 286-293
|
|
Immunologic therapy for secondary and primary progressive multiple sclerosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BETA INTERFERON;
BETA1A INTERFERON;
CLADRIBINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
GLATIRAMER;
IMMUNOGLOBULIN;
IMMUNOLOGICAL ADJUVANT;
IMMUNOSUPPRESSIVE AGENT;
INTERFERON BETA SERINE;
INTERFERON BETA-1B;
LYMPHOCYTE ANTIBODY;
MITOXANTRONE;
PEPTIDE;
STEROID;
ADULT;
AUTOIMMUNE DISEASE;
CLASSIFICATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FORECASTING;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOLOGY;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
MULTIPLE SCLEROSIS;
PLASMAPHERESIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
T LYMPHOCYTE;
TRANSPLANTATION;
TREATMENT OUTCOME;
VACCINATION;
ADJUVANTS, IMMUNOLOGIC;
ADRENAL CORTEX HORMONES;
ADULT;
ANTI-INFLAMMATORY AGENTS;
ANTILYMPHOCYTE SERUM;
AUTOIMMUNE DISEASES;
CLADRIBINE;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DISEASE PROGRESSION;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FORECASTING;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERON-BETA;
MIDDLE AGED;
MITOXANTRONE;
MULTICENTER STUDIES;
MULTIPLE SCLEROSIS;
PEPTIDES;
PLASMA EXCHANGE;
RANDOMIZED CONTROLLED TRIALS;
STEROIDS;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
VACCINATION;
|
|
EID: 0035352923
PISSN: 15284042
EISSN: None
Source Type: Journal
DOI: 10.1007/s11910-001-0032-8 Document Type: Review |
|
Times cited : (7)
|
|
References (50)
|
